Best Biopharma Outsourcing Companies in Georgia, United States
The 34 best Biopharma Outsourcing companies in Georgia, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Antios Therapeutics.
Our analysis of 50 Biopharma Outsourcing companies
$6.3b in tracked funding; 77% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Georgia
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Antios Therapeutics Developer of innovative therapies to treat and cure viral diseases | $200M | 59 mo ago | Series B | Abel De La Rosa Co-Founder & CEO | 2018 | — | — | — |
| 2 | Vaccinogen Biotechnology company developing cancer vaccine | $19M | 131 mo ago | Series A | Hanna Michael Founder | 2007 | — | 6 patents Personalized autologous tumor antigen vaccines for adenocarcinoma immunotherapy. | — |
| 3 | Emtherapro CRO focused on drugs discovery, biomarker identification, validation, and clinical trials services | $3M | 37 mo ago | Seed | Nicholas Seyfried Co-Founder & CSO | 2021 | — | — | — |
| 4 | Aavis Pharmaceuticals USFDA-approved pharmaceutical company specializing in generic drug development and contract manufacturing | $1M | 108 mo ago | Seed | — | 2015 | PleskWindows ServerAnimate.css+9 | — | — |
| 5 | Brain Trust Bio Provider of contract based drugs delivery services for CNS disorders | $400K | 67 mo ago | Seed | Chen Benkler Co-Founder & CEO | 2019 | — | — | — |
| 6 | Renovo Pharmaceutical cocrystal and salt screening services for improved drug performance | $150K | 177 mo ago | Funding Raised | — | 2008 | — | 6 patents Personalized drug efficacy testing and anti‑scar biologics using engineered proteins | — |
| 7 | Agile CRO conducts clinical trials and patient management services | — | — | Unfunded | — | 2012 | — | 47 patents Tunable acoustic resonators, BST ferroelectric passivation, and dual‑band RF antenna components | — |
| 8 | Aquila Solutions Provider of eCTD regulatory publishing, consulting, and SPL authoring services | — | — | Unfunded | — | 2009 | Google CloudTypekitcore-js+11 | 9 patents Patents concentrated in transport & manufacturing processes | — |
Top 6 Biopharma Outsourcing companies in Georgia
#1
Seed · Decatur, Georgia · founded 2021$3Mraised▾
Developer of diagnostic assays designed to cure Alzheimer's disease. The company specializes in the treatment of neurodegenerative diseases through precision proteomics, in which proteins from the cerebrospinal fluid are analyzed as biomarkers using an assay, helping medical practitioners to detect pathologies associated with Alzheimer's disease.
- Sep 2023Seed$3M
#2
Series B · Atlanta, Georgia · founded 2018 · 22 employees$200.4Mraised▾
Developer of innovative therapies to treat and cure viral diseases
- Nov 2021Series B$75M
- Apr 2021Series B$96M
- Aug 2020Series A$4.4M
- Nov 2018Series A$25M
#3
Series A · Savannah, Georgia · founded 2007 · 24 employees$18.9Mraised▾
Vaccinogen Inc. is a biotechnology company based in Savannah, GA. They are focused on developing OncoVAX, an autologous cancer vaccine that utilizes a patient's own tumor cells to launch a customized immune response. OncoVAX has shown promising results in reducing the risk of recurrence and increasing disease-free survival for Stage II Colon Cancer patients.
- Oct 2015Series A$600K
- Oct 2012Series A$6.6M
- Feb 2010Series A$7.6M
- Dec 2008Series A$4M
#4
Seed · Brookhaven, Georgia · founded 2019$400Kraised▾
Developer of a platform intended to serve patients and families affected by central nervous system diseases. The company focuses on the testing and commercialization of riluzole administered by intrathecal infusion (ITRil) for the treatment of amyotrophic lateral sclerosis, enabling patients suffering from neurological diseases with life-altering medicines a direct route to the body without the roadblocks and side effects.
- Mar 2021Seed$400K
#5
Seed · Hoschton, Georgia · founded 2015 · 36 employees$1.1Mraised▾
USFDA-approved pharmaceutical company specializing in generic drug development and contract manufacturing. The company focuses on research and development of immediate and controlled-release oral solids, navigating complex formulations with competitive barriers to entry. It continuously researches new formulations for existing products to enhance therapeutic efficiency and develops new drug molecules to improve patient compliance. Services encompass R&D, scale-up, contract manufacturing, exhibit batches, clinical studies, commercial manufacturing, analytical method development, and validation with stability studies. The company is dedicated to providing high-quality pharmaceuticals through proficient research and development, adhering to stringent quality commitments.
- Oct 2017Seed$600K
- Feb 2017Seed$500K
#6
Funding Raised · Atlanta, Georgia · founded 2008$150Kraised▾
Pharmaceutical cocrystal and salt screening services for improved drug performance. A contract research organization specializing in pharmaceutical cocrystals as an enabling technology for improving physical properties and drug delivery. It performs fee-for-service contract research to identify new, patentable, multi-component crystalline solid forms of active pharmaceutical ingredients (APIs) that can significantly improve physical properties, leading to improved drug product performance and bioavailability. The company delivers novel and innovative solutions to challenging problems in pharmaceutical product development, providing enabling technology for improvements in drug products and patent protection for market exclusivity. Services include cocrystal screening and salt screening.
- Jan 2012Grant (prize money)$150K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology in Georgia is moving
A read on the academic research around Biotechnology in Georgia — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 94 papers.
- University of Georgia51
- Georgia Institute of Technology16
- Georgia State University15
- Georgia Southern University4
- Georgia Regents Medical Center2
- Cultivar3
- Antigen2
- Resistance (ecology)2
- In vivo2
- Recombinant DNA2
- Biomass (ecology)4
- Population4
- Fluorescence3
- Biofuel3
- Cancer cell2
- Agriculture3
- Antibiotic resistance3
- Nutrient2
- Livestock2
- Resistance (ecology)2
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.